Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

The effect of hydrazine sulfate on prostate cancer growth.

Kamradt JM, Pienta KJ.

Oncol Rep. 1998 Jul-Aug;5(4):919-21.

PMID:
9625846
2.

An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.

Naik HR, Lehr JE, Pienta KJ.

Anticancer Res. 1994 Nov-Dec;14(6B):2617-9.

PMID:
7872690
3.

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.

Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.

Urology. 1997 Dec;50(6):999-1006.

PMID:
9426741
4.

Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.

Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.

Cancer Epidemiol Biomarkers Prev. 1999 Mar;8(3):241-8.

5.

In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.

Sarosdy MF, Higdon AL, Demoor CA.

J Urol. 1996 Jun;155(6):2085-9.

PMID:
8618341
6.

Oral bropirimine immunotherapy of rodent prostate cancer.

Sarosdy MF.

Eur Urol. 1997;31 Suppl 1:5-9.

PMID:
9076480
7.

The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model.

Pilat MJ, Lehr JE, Quigley MM, Pienta KJ.

Oncol Rep. 1998 Jul-Aug;5(4):889-92.

PMID:
9625839
8.

Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.

Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A.

J Natl Cancer Inst. 1995 Mar 1;87(5):348-53.

PMID:
7853416
9.

PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .

Kubota T, Hisatake J, Hisatake Y, Said JW, Chen SS, Holden S, Taguchi H, Koeffler HP.

Prostate. 2000 Feb 15;42(3):163-71.

PMID:
10639186
10.

The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.

Nguyen NM, Lehr JE, Shelley CI, Andersen JC, Pienta KJ.

Anticancer Res. 1993 Nov-Dec;13(6A):2053-8.

PMID:
7507653
11.

Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.

Nguyen NM, Lehr JE, Pienta KJ.

Anticancer Res. 1993 Nov-Dec;13(6A):2143-7.

PMID:
7507655
13.

An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.

Dandekar DS, Lokeshwar VB, Cevallos-Arellano E, Soloway MS, Lokeshwar BL.

Cancer Chemother Pharmacol. 2003 Jul;52(1):59-66. Epub 2003 May 7.

PMID:
12734674
14.

Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.

Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A.

Int J Oncol. 1999 Apr;14(4):713-9.

PMID:
10087319
15.

Inhibition of prostate cancer growth by vinblastine and tamoxifen.

Pienta KJ, Replogle T, Lehr JE.

Prostate. 1995 May;26(5):270-4.

PMID:
7753712
16.

[Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].

Filov VA, Burova TM.

Biull Eksp Biol Med. 1984 Jan;97(1):73-4. Russian.

PMID:
6692028
17.

Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.

Weeraratna AT, Dalrymple SL, Lamb JC, Denmeade SR, Miknyoczki S, Dionne CA, Isaacs JT.

Clin Cancer Res. 2001 Aug;7(8):2237-45.

18.

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.

Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ.

Prostate. 2004 Mar 1;58(4):382-93.

PMID:
14968439
19.

Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo.

Garde S, Sheth A, Porter AT, Pienta KJ.

Prostate. 1993;22(3):225-33.

PMID:
8488155
20.

Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.

Rabbani SA, Harakidas P, Bowlin T, Attardo G.

Cancer Res. 1998 Aug 1;58(15):3461-5.

Supplemental Content

Support Center